IBDEI16E ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19079,1,4,0)
 ;;=4^F17.291
 ;;^UTILITY(U,$J,358.3,19079,2)
 ;;=^5003376
 ;;^UTILITY(U,$J,358.3,19080,0)
 ;;=F17.290^^64^848^11
 ;;^UTILITY(U,$J,358.3,19080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19080,1,3,0)
 ;;=3^Nicotine Dependence,Oth Tobacco Product,Uncomplicated
 ;;^UTILITY(U,$J,358.3,19080,1,4,0)
 ;;=4^F17.290
 ;;^UTILITY(U,$J,358.3,19080,2)
 ;;=^5003375
 ;;^UTILITY(U,$J,358.3,19081,0)
 ;;=F17.201^^64^848^12
 ;;^UTILITY(U,$J,358.3,19081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19081,1,3,0)
 ;;=3^Nicotine Dependence,Unspec,In Remission
 ;;^UTILITY(U,$J,358.3,19081,1,4,0)
 ;;=4^F17.201
 ;;^UTILITY(U,$J,358.3,19081,2)
 ;;=^5003361
 ;;^UTILITY(U,$J,358.3,19082,0)
 ;;=F17.200^^64^848^13
 ;;^UTILITY(U,$J,358.3,19082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19082,1,3,0)
 ;;=3^Nicotine Dependence,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,19082,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,19082,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,19083,0)
 ;;=F19.20^^64^848^17
 ;;^UTILITY(U,$J,358.3,19083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19083,1,3,0)
 ;;=3^Psycoactive Substance Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,19083,1,4,0)
 ;;=4^F19.20
 ;;^UTILITY(U,$J,358.3,19083,2)
 ;;=^5003431
 ;;^UTILITY(U,$J,358.3,19084,0)
 ;;=F43.11^^64^848^14
 ;;^UTILITY(U,$J,358.3,19084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19084,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,19084,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,19084,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,19085,0)
 ;;=F43.12^^64^848^15
 ;;^UTILITY(U,$J,358.3,19085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19085,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,19085,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,19085,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,19086,0)
 ;;=F43.10^^64^848^16
 ;;^UTILITY(U,$J,358.3,19086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19086,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,19086,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,19086,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,19087,0)
 ;;=Z87.891^^64^848^4
 ;;^UTILITY(U,$J,358.3,19087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19087,1,3,0)
 ;;=3^Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,19087,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,19087,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,19088,0)
 ;;=F32.A^^64^848^3
 ;;^UTILITY(U,$J,358.3,19088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19088,1,3,0)
 ;;=3^Depression,Unspec
 ;;^UTILITY(U,$J,358.3,19088,1,4,0)
 ;;=4^F32.A
 ;;^UTILITY(U,$J,358.3,19088,2)
 ;;=^5161153
 ;;^UTILITY(U,$J,358.3,19089,0)
 ;;=L40.2^^64^849^1
 ;;^UTILITY(U,$J,358.3,19089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19089,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,19089,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,19089,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,19090,0)
 ;;=L03.91^^64^849^2
 ;;^UTILITY(U,$J,358.3,19090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19090,1,3,0)
 ;;=3^Acute Lymphangitis,Unspec
 ;;^UTILITY(U,$J,358.3,19090,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,19090,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,19091,0)
 ;;=L23.9^^64^849^3
 ;;^UTILITY(U,$J,358.3,19091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19091,1,3,0)
 ;;=3^Allergic Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,19091,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,19091,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,19092,0)
 ;;=L03.90^^64^849^4
